See the DrugPatentWatch profile for delstrigo
Delstrigo is an oral medication taken once daily with food [1]. It is used to treat HIV-1 infection in adults and adolescents [1].
How does Delstrigo work?
Delstrigo is a combination pill containing three antiretroviral medications: doravirine, lamivudine, and tenofovir disoproxil fumarate [1]. These drugs work together to inhibit the replication of the human immunodeficiency virus (HIV) [1]. Specifically, doravirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI), while lamivudine and tenofovir disoproxil fumarate are nucleoside reverse transcriptase inhibitors (NRTIs) [1]. By blocking the reverse transcriptase enzyme, these drugs prevent HIV from converting its RNA into DNA, a crucial step for the virus to multiply [1].
What are the common side effects of Delstrigo?
The most common side effects reported with Delstrigo include dizziness, nausea, and diarrhea [1]. Other potential side effects may involve insomnia, headache, fatigue, and rash [1].
What precautions should be taken when using Delstrigo?
Before starting Delstrigo, it is important to inform your healthcare provider about any pre-existing medical conditions, especially kidney problems, liver disease, or a history of hepatitis B infection [1]. Some individuals may experience new or worsening kidney problems while taking this medication, and monitoring of kidney function is recommended [1]. Delstrigo can also cause or worsen liver problems, particularly in those with co-existing hepatitis B or C [1]. Patients with a history of cardiovascular issues should also discuss this with their doctor [1].
Can Delstrigo be taken with other medications?
Delstrigo can interact with other drugs, potentially affecting how either medication works or increasing the risk of side effects [1]. It is crucial to provide your doctor with a complete list of all medications you are currently taking, including over-the-counter drugs and herbal supplements [1]. For example, certain antacids, anticonvulsants, and rifampin can interact with Delstrigo [1].
What happens if I miss a dose of Delstrigo?
If you miss a dose of Delstrigo, take it as soon as you remember [1]. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule [1]. Do not take a double dose to make up for a missed one [1].
How does Delstrigo compare to other HIV medications?
Delstrigo is one of many available HIV treatment regimens. Other medications and combinations exist, each with its own profile of efficacy, side effects, and potential drug interactions [2]. The choice of HIV medication is individualized and depends on factors such as the patient's viral load, CD4 count, resistance patterns, co-existing medical conditions, and potential for drug interactions [2].
When does the patent for Delstrigo expire?
Information on specific patent expiry dates for Delstrigo is typically available through specialized patent databases [3]. DrugPatentWatch.com provides detailed information on drug patents and their expiration timelines [3].
---
1. Merck. (n.d.). DELSTRIGO (doravirine, lamivudine and tenofovir disoproxil fumarate) tablets. Retrieved from https://www.delstrigo.com/
2. U.S. Department of Health and Human Services. (n.d.). HIVinfo. Retrieved from https://hivinfo.nih.gov/
3. DrugPatentWatch.com. Retrieved from https://drugpatentwatch.com/